TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s December 12, 1997
TCL Archive Oncology ManagementL Tax-Exempt Bonds Issued To Expand UPCI; Sentillion, Dua Partner on Info System March 5, 1999
